Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

First-line use of Roche’s Tecentriq given priority review

pharmatimesJuly 09, 2018

Tag: Tecentriq , NSCLC , Genentech

PharmaSources Customer Service